137 related articles for article (PubMed ID: 4587755)
21. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and incompatible tumor cells.
Klein E; Klein G
Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5056574
[No Abstract] [Full Text] [Related]
22. [Transplantable ascitic tumor derived from a mouse with moloney sarcoma: tumorigenic, antigenic and virologic properties (author's transl)].
Weiland E; Weiland F
Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):151-61. PubMed ID: 4283271
[No Abstract] [Full Text] [Related]
23. Breakdown of Friend virus-induced tolerance and development of runting syndrome in rats.
Takeichi N; Kaji H; Kodama T; Kobayashi H
Cancer Res; 1974 Mar; 34(3):543-50. PubMed ID: 4812261
[No Abstract] [Full Text] [Related]
24. Depression of antilymphoma allograft reactivity by tumor-associated factors.
Bonmassar E; Bonmassar A; Goldin A; Cudkowicz G
Cancer Res; 1973 May; 33(5):1054-61. PubMed ID: 4703118
[No Abstract] [Full Text] [Related]
25. Effect of cortisone on oncogenesis by murine sarcoma virus (Moloney).
Shachat DA; Fefer A; Moloney JB
Cancer Res; 1968 Mar; 28(3):517-20. PubMed ID: 4867925
[No Abstract] [Full Text] [Related]
26. Antigen fluctuation and virus activation in EL 4 cells transplanted in hybrid mice or cultured in vitro.
Colnaghi MI; Pierotti MA; Torre GD; Miotti S
J Natl Cancer Inst; 1977 Jul; 59(1):123-30. PubMed ID: 195063
[No Abstract] [Full Text] [Related]
27. Variation of antigenic characteristics between different mouse lymphomas induced by the Moloney virus.
Klein G; Klein E; Haughton G
J Natl Cancer Inst; 1966 Apr; 36(4):607-21. PubMed ID: 4286935
[No Abstract] [Full Text] [Related]
28. Factors related to therapeutic efficacy in adoptive chemoimmunotherapy of a Friend virus-induced lymphoma.
Fass L; Fefer A
Cancer Res; 1972 Nov; 32(11):2427-31. PubMed ID: 5082591
[No Abstract] [Full Text] [Related]
29. Immunoprophylaxis and immunotherapy of EL4 lymphoma.
Ghose T; Guclu A; Tai J; Mammen M; Norvell ST
Eur J Cancer (1965); 1977 Sep; 13(9):925-35. PubMed ID: 913475
[No Abstract] [Full Text] [Related]
30. Endotoxin-stimulated immune response to modified lymphoma cells.
Prager MD; Ludden CM; Mandy WJ; Allison JP; Kitto GB
J Natl Cancer Inst; 1975 Mar; 54(3):773-5. PubMed ID: 1168264
[TBL] [Abstract][Full Text] [Related]
31. Dynamic alterations in some surface properties of freshly explanted Moloney lymphoma cells.
Ran M; Eshel I; Witz IP; Klein G
J Natl Cancer Inst; 1975 Oct; 55(4):843-9. PubMed ID: 1185807
[TBL] [Abstract][Full Text] [Related]
32. Tumor-bound immunoglobulins: an in vivo phenomenon of masked specificity.
Dorval G; Wilz IP; Klein E; Wigzell H
J Natl Cancer Inst; 1976 Mar; 56(3):523-7. PubMed ID: 56447
[TBL] [Abstract][Full Text] [Related]
33. Influence of infectious virus on the induction of transplantation resistance in the Friend tumor system.
McCoy JL; Fefer A; Glynn JP
Cancer Res; 1967 Dec; 27(12):2267-71. PubMed ID: 4866760
[No Abstract] [Full Text] [Related]
34. Virus expression and immunoprophylaxis of a murine lymphoma.
Sekine I; Vredevoe DL; Hays EF
J Natl Cancer Inst; 1975 Mar; 54(3):727-31. PubMed ID: 164567
[TBL] [Abstract][Full Text] [Related]
35. Suppression of natural killer cell activity with radioactive strontium: effector cells are marrow dependent.
Haller O; Wigzell H
J Immunol; 1977 Apr; 118(4):1503-6. PubMed ID: 300411
[TBL] [Abstract][Full Text] [Related]
36. [Antibodies to the autologous tumor cells in tumor induction in mice using methylcholanthrene].
Vetrova EP; Fedorovskaia MI; Kaminskaia LP; Umanskiĭ IuA
Vopr Onkol; 1974; 20(3):59-62. PubMed ID: 4612978
[No Abstract] [Full Text] [Related]
37. Immunological stimulation with modified lymphoma cells in a minimally responsive tumor-host system.
Prager MD; Baechtel FS; Ribble RJ; Ludden CM; Mehta JM
Cancer Res; 1974 Dec; 34(12):3203-9. PubMed ID: 4429949
[No Abstract] [Full Text] [Related]
38. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells.
Klein E; Klein G
Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5078988
[No Abstract] [Full Text] [Related]
39. Progressive loss of H-2 antigens with concomitant increase of cell-surface antigen(s) determined by Moloney leukemia virus in cultured murine lymphomas.
Cikes M; Friberg S; Klein G
J Natl Cancer Inst; 1973 Feb; 50(2):347-62. PubMed ID: 4573851
[No Abstract] [Full Text] [Related]
40. Antibody-dependent cellular cytotoxicity to a syngeneic Gross virus-induced lymphoma.
Ortiz de Landazuri M; Kedar E; Fahey JL
J Natl Cancer Inst; 1974 Jan; 52(1):147-52. PubMed ID: 4204244
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
